We are only able to display limited information for this firm. We display more complete information for all of the following firms:

As a ‘very strong team with comprehensive knowledge of both English and Scottish relevant law’, Morton Fraser MacRoberts is regularly sought out by multinational corporates and private equity outfits for its expertise in handling substantial M&A, corporate restructurings, and joint ventures. The energy, logistics, and professional services sectors are big generators of instructions, as well as the healthcare space, where the firm has received an increased stream of equity investments and M&A deals. Team lead Alan Kelly is a trusted adviser and ’safe pair of hands’ for a variety of public and private entities and is equally proficient across corporate and corporate finance mandates. Paul Geoghegan has recently been particularly active in the professional services sector, and Michael Kelly and Gary Baines have focused on sell-side and buy-side M&A, respectively. David Wylie heads up the firm’s healthcare group and regularly engages with M&A and PE deals in this space, while Bonar Mercer was promoted to partner in 2023.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team is very strong, with comprehensive knowledge of both English and Scottish relevant law. They are also calm under stress and consistently provide good and appropriate counsel, based on pragmatism. They are also highly efficient and a pleasure to work with.’

  • ‘Morton Fraser MacRoberts provided exceptional support and guidance on corporate, tax and employment during the sale of the business. The Morton Fraser MacRoberts team was outstanding, proactive and solutions-focused throughout the deal negotiations, due diligence and completion.'

Abbreviated data is displayed for this firm.

Key clients

  • Breedon Aggregates
  • SSE Heat Networks
Abbreviated data is displayed for this firm.

Work highlights

  • Advised the core Dears Healthcare corporate group on the acquisition of 15 Lloyds Pharmacy branches.
  • Acted for Life Sciences company Dxcover Limited on the preparation, negotiation and completion of the equity investment into Dxcover Limited made by a number of investors including Eos Advisory LLP, Mercia Fund Management and Norcliffe Capital.
Abbreviated data is displayed for this firm.